Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:
Sirius XM Radio (SIRI) : "I'd hold it. I've been consistently behind this one and I'm not backing away."
Teva Pharmaceuticals (TEVA) : "It's had a nice comeback but I don't want to pull the trigger."
Blue Apron (APRN) : "I don't have a reason to own it."
Shopify (SHOP) : "I think Shopify will not be killed and you can continue to own it."
Incyte (INCY) : "I thought their new drug was a winner but no one believes me."
E*TRADE Financial (ETFC) : "They are in the sweet spot."
Cramer and the AAP team note that new home sales in the first quarter were not as strong as previously thought. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Over on Real Money, Cramer on why the market turned against Toll Brothers (TOL) . Get more of his insights with a free trial subscription to Real Money.
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To read a full recap of this episode of "Mad Money," click here.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.